Drug:
Reaction: DEATH
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26935176 |
CA |
80 | 1 |
Death, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 202 | 26935199 |
GB |
1 | |
Death, |
||||
NINTEDANIB, |
||||
| 203 | 26935210 |
US |
2 | |
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 204 | 26935211 |
US |
83 | 1 |
Death, |
||||
| 205 | 26935274 |
CA |
67 | 2 |
Death, |
||||
SOTORASIB, SOTORASIB, |
||||
| 206 | 26935292 |
CA |
1 | |
Death, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, DEGARELIX, |
||||
| 207 | 26935300 |
KR |
||
Death, Inappropriate schedule of product administration, |
||||
SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, |
||||
| 208 | 26935329 |
US |
84 | |
Death, |
||||
MITOMYCIN, MITOMYCIN, |
||||
| 209 | 26935353 |
US |
81 | 1 |
Death, |
||||
PERFLUOROHEXYLOCTANE, |
||||
| 210 | 26935381 |
JP |
8 | 1 |
Death, |
||||
TALQUETAMAB, |
||||
| 211 | 26935390 |
US |
||
Death, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 212 | 26935396 |
JP |
1 | |
Death, Malignant neoplasm progression, |
||||
PEMBROLIZUMAB, |
||||
| 213 | 26935410 |
US |
||
Death, |
||||
AMBRISENTAN, |
||||
| 214 | 26935437 |
US |
1 | |
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 215 | 26935448 |
ID |
71 | 1 |
Death, |
||||
DURVALUMAB, |
||||
| 216 | 26935480 |
US |
52 | |
Death, |
||||
ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, CARVEDILOL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PROPRANOLOL HYDROCHLORIDE, INSULIN ASPART, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, PREDNISONE, TOPIRAMATE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, TACROLIMUS, SULFAMETHOXAZOLE AND TRIMETHOPRIM, |
||||
| 217 | 26935491 |
US |
87 | 2 |
Death, |
||||
OSIMERTINIB, |
||||
| 218 | 26935510 |
EU |
1 | |
Death, |
||||
ODEVIXIBAT, |
||||
| 219 | 26935533 |
ID |
81 | 1 |
Death, |
||||
ACALABRUTINIB, |
||||
| 220 | 26935538 |
CA |
1 | |
Death, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 221 | 26935542 |
ID |
72 | 1 |
Death, |
||||
OSIMERTINIB, |
||||
| 222 | 26935562 |
US |
2 | |
Death, |
||||
CERTOLIZUMAB PEGOL, CALCIUM, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, AMLODIPINE BESYLATE AND VALSARTAN, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
| 223 | 26935614 |
CA |
82 | 1 |
Death, Pain, Intentional product use issue, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 224 | 26935656 |
US |
41 | 1 |
Death, |
||||
RIFAXIMIN, |
||||
| 225 | 26935658 |
EU |
29 | 1 |
Death, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, QUETIAPINE, MIRTAZAPINE, METHADONE, |
||||
| 226 | 26935659 |
EU |
33 | 1 |
Death, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, METHADONE, |
||||
| 227 | 26935666 |
JP |
57 | |
Death, Interstitial lung disease, Nausea, Decreased appetite, Diarrhoea, Constipation, Therapy non-responder, |
||||
SACITUZUMAB GOVITECAN, |
||||
| 228 | 26935668 |
|||
Death, |
||||
VIGABATRIN, |
||||
| 229 | 26935678 |
US |
83 | 2 |
Death, |
||||
ACALABRUTINIB, MELATONIN, |
||||
| 230 | 26935681 |
US |
85 | 1 |
Death, |
||||
OLAPARIB, |
||||
| 231 | 26935683 |
US |
1 | |
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 232 | 26935686 |
GB |
1 | |
Death, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 233 | 26935750 |
CA |
78 | 1 |
Death, |
||||
DURVALUMAB, |
||||
| 234 | 26935752 |
US |
2 | |
Death, |
||||
| 235 | 26935758 |
US |
2 | |
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 236 | 26935766 |
US |
2 | |
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 237 | 26935787 |
SA |
59 | 1 |
Death, |
||||
EVOLOCUMAB, |
||||
| 238 | 26935817 |
EU |
||
Death, |
||||
CABOTEGRAVIR, CABOTEGRAVIR, CABOTEGRAVIR, RILPIVIRINE, |
||||
| 239 | 26935826 |
GB |
||
Chills, Vomiting, Cytokine release syndrome, Death, |
||||
OBINUTUZUMAB, GLOFITAMAB, |
||||
| 240 | 26935879 |
US |
89 | |
Death, |
||||
LENALIDOMIDE, |
||||
| 241 | 26935906 |
IN |
56 | 2 |
Death, |
||||
OSIMERTINIB, |
||||
| 242 | 26935927 |
US |
1 | |
Death, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 243 | 26935940 |
ID |
57 | 1 |
Death, |
||||
OSIMERTINIB, |
||||
| 244 | 26935947 |
US |
84 | 1 |
Death, |
||||
NERANDOMILAST, |
||||
| 245 | 26935953 |
NP |
26 | 1 |
Death, |
||||
| 246 | 26936013 |
CN |
||
Death, |
||||
RITUXIMAB, LONCASTUXIMAB TESIRINE, |
||||
| 247 | 26936028 |
CO |
76 | 2 |
Death, |
||||
DENOSUMAB, |
||||
| 248 | 26936039 |
US |
1 | |
Death, |
||||
OSIMERTINIB, |
||||
| 249 | 26936063 |
BR |
1 | |
Death, |
||||
| 250 | 26936064 |
US |
59 | |
Death, |
||||
| 251 | 26936068 |
NZ |
79 | 2 |
Death, |
||||
CLOZAPINE, |
||||
| 252 | 26936071 |
CA |
44 | 2 |
Death, |
||||
CLOZAPINE, |
||||
| 253 | 26936079 |
US |
65 | 1 |
Death, |
||||
OSIMERTINIB, |
||||
| 254 | 26936115 |
GB |
1 | |
Death, |
||||
| 255 | 26936117 |
CA |
67 | 2 |
Death, |
||||
CLOZAPINE, |
||||
| 256 | 26936179 |
US |
2 | |
Death, |
||||
OLAPARIB, |
||||
| 257 | 26936222 |
HN |
1 | |
Death, |
||||
| 258 | 26936233 |
68 | ||
Death, |
||||
BUDESONIDE, |
||||
| 259 | 26936240 |
US |
2 | |
Death, Unevaluable event, |
||||
BRENSOCATIB, |
||||
| 260 | 26936243 |
CA |
39 | 2 |
Death, Acute myeloid leukaemia, |
||||
VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 261 | 26936280 |
US |
89 | 2 |
Death, |
||||
PIMAVANSERIN TARTRATE, DONEPEZIL HYDROCHLORIDE, QUETIAPINE, LEVOTHYROXINE SODIUM, |
||||
| 262 | 26936401 |
US |
69 | 2 |
Death, |
||||
OSIMERTINIB, DULOXETINE HYDROCHLORIDE, DULOXETINE, FAMOTIDINE, MORPHINE, OLANZAPINE, |
||||
| 263 | 26936408 |
US |
2 | |
Death, |
||||
ETANERCEPT, |
||||
| 264 | 26936446 |
IN |
65 | 2 |
Death, |
||||
ATEZOLIZUMAB, |
||||
| 265 | 26936470 |
CN |
||
Death, |
||||
RITUXIMAB, |
||||
| 266 | 26936499 |
CN |
||
Death, |
||||
RITUXIMAB, LONCASTUXIMAB TESIRINE, |
||||
| 267 | 26936531 |
EU |
90 | 1 |
Death, |
||||
TAFAMIDIS MEGLUMINE, |
||||
| 268 | 26936578 |
GB |
64 | 1 |
Death, |
||||
INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, |
||||
| 269 | 26936590 |
CN |
||
Death, |
||||
RITUXIMAB, LONCASTUXIMAB TESIRINE, |
||||
| 270 | 26936628 |
CN |
||
Death, |
||||
RITUXIMAB, LONCASTUXIMAB TESIRINE, |
||||
| 271 | 26936788 |
US |
67 | |
Death, |
||||
VUTRISIRAN, |
||||
| 272 | 26936802 |
CO |
1 | |
Death, |
||||
LORLATINIB, |
||||
| 273 | 26936806 |
IN |
81 | 1 |
Death, Weight decreased, Movement disorder, Memory impairment, Balance disorder, Hypoacusis, Constipation, Asthenia, |
||||
CRIZOTINIB, CRIZOTINIB, CRIZOTINIB, CRIZOTINIB, |
||||
| 274 | 26936826 |
US |
73 | |
Death, |
||||
VUTRISIRAN, |
||||
| 275 | 26936834 |
US |
66 | 2 |
Death, |
||||
LORLATINIB, |
||||
| 276 | 26936874 |
US |
2 | 1 |
Neuroblastoma recurrent, Hyperthyroidism, Deafness, Speech disorder developmental, Off label use, Metastasis, Death, |
||||
| 277 | 26936878 |
CN |
76 | 1 |
Death, Gastrointestinal stromal tumour, Malignant neoplasm progression, Cardiac disorder, |
||||
| 278 | 26936927 |
US |
1 | |
Death, |
||||
DORDAVIPRONE, |
||||
| 279 | 26936989 |
CN |
||
Death, |
||||
RITUXIMAB, LONCASTUXIMAB TESIRINE, |
||||
| 280 | 26937013 |
US |
26 | |
Death, Off label use, |
||||
RUXOLITINIB, ACYCLOVIR, ELTROMBOPAG, ELTROMBOPAG OLAMINE, FOLIC ACID, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXYCODONE, BENZOYL PEROXIDE, SALICYLIC ACID, ADAPALENE, PROCHLORPERAZINE, ZOLPIDEM TARTRATE, |
||||
| 281 | 26937076 |
EU |
2 | |
Death, |
||||
ACALABRUTINIB, |
||||
| 282 | 26937155 |
CN |
||
Death, |
||||
RITUXIMAB, LONCASTUXIMAB TESIRINE, |
||||
| 283 | 26937197 |
CN |
||
Death, |
||||
RITUXIMAB, LONCASTUXIMAB TESIRINE, |
||||
| 284 | 26937218 |
CN |
||
Death, |
||||
RITUXIMAB, LONCASTUXIMAB TESIRINE, |
||||
| 285 | 26937299 |
US |
72 | 1 |
Death, |
||||
PERFLUOROHEXYLOCTANE, LIFITEGRAST, FOSCARBIDOPA/FOSLEVODOPA, LINACLOTIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MIRABEGRON, TESTOSTERONE, PEGVISOMANT, LEVOTHYROXINE SODIUM, ROSUVASTATIN, PREDNISONE, |
||||
| 286 | 26937314 |
GB |
89 | |
Death, |
||||
INFLIXIMAB-DYYB, |
||||
| 287 | 26937324 |
US |
70 | 1 |
Death, |
||||
PERFLUOROHEXYLOCTANE, BECLOMETHASONE DIPROPIONATE, AZELASTINE, CLONIDINE, VALSARTAN, VALSARTAN ORAL, AMLODIPINE, HYDROCHLOROTHIAZIDE, FLUTICASONE FUROATE, |
||||
| 288 | 26937364 |
EU |
84 | 2 |
Death, |
||||
NIVOLUMAB, |
||||
| 289 | 26937433 |
US |
81 | |
Death, |
||||
VUTRISIRAN, |
||||
| 290 | 26937434 |
CA |
||
Death, |
||||
VUTRISIRAN, |
||||
| 291 | 26937435 |
US |
77 | |
Death, Hospitalisation, |
||||
VUTRISIRAN, VUTRISIRAN, FUROSEMIDE, ROSUVASTATIN, TAFAMIDIS, |
||||
| 292 | 26937485 |
US |
86 | |
Death, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 293 | 26937562 |
IN |
90 | 1 |
Death, |
||||
| 294 | 26937567 |
US |
2 | |
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 295 | 26937715 |
CN |
||
Death, |
||||
RITUXIMAB, LONCASTUXIMAB TESIRINE, |
||||
| 296 | 26937719 |
BR |
60 | 1 |
Death, |
||||
BEVACIZUMAB, ATEZOLIZUMAB, |
||||
| 297 | 26937733 |
40 | ||
Death, |
||||
CETUXIMAB, |
||||
| 298 | 26937748 |
EU |
83 | 2 |
Death, |
||||
ABEMACICLIB, |
||||
| 299 | 26937793 |
EU |
29 | 1 |
Death, |
||||
MIRTAZAPINE, QUETIAPINE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, METHADONE, |
||||
| 300 | 26937822 |
|||
Death, |
||||
RAMUCIRUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30